Association of malignancy with diseases causing interstitial pulmonary changes

Chest

Volumn 121, Issue 4, 2002, Pages 1278-1289

  Bouros, Demosthenes ^a   Hatzakis, Kostas ^a   Labrakis, Haris ^a   Zeibecoglou, Kyriaki ^a  

^a UNIVERSITY OF CRETE   (Greece)

Author keywords

Asbestosis; Cancer; Lung cancer; Malignancy; Pulmonary fibrosis; Sarcoidosis; Scar cancer

Indexed keywords

ALKYLATING AGENT; ASBESTOS; AZATHIOPRINE; BERYLLIUM; CARCINOGEN; COAL; CYCLOSPORIN A; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; SILICON DIOXIDE;

ASBESTOSIS; BERYLLIOSIS; CANCER RISK; CARCINOGENESIS; COAL WORKER; DERMATOMYOSITIS; DISEASE ASSOCIATION; DISEASE COURSE; HISTIOCYTOSIS X; HUMAN; IDIOPATHIC DISEASE; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATORY CELL; INTERSTITIAL LUNG DISEASE; LUNG ALVEOLITIS; LUNG CARCINOMA; LUNG FIBROSIS; LUNG PARENCHYMA; LUNG TOXICITY; MALIGNANT NEOPLASTIC DISEASE; MEDICAL RESEARCH; MOLECULAR BIOLOGY; NONHODGKIN LYMPHOMA; NONHUMAN; OCCUPATIONAL DISEASE; PATHOGENESIS; PNEUMOCONIOSIS; POLYMYOSITIS; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; SARCOIDOSIS; SCAR; SILICOSIS; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS;

EID: 0036209103     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.121.4.1278     Document Type: Review

References (129)

1. Diffuse interstitial pulmonary fibrosis and lung cancer
2. Lung cancer in patients with idiopathic pulmonary fibrosis
3. Asbestos exposure and neoplasia
4. Carcinoma and diffuse interstitial fibrosis of lung
5. Idiopathic diffuse interstitial pulmonary fibrosis (fibrosing alveolitis), atypical epithelial proliferation and lung cancer
6. Lung scar cancers
7. Carcinoembryonic antigen in bronchoalveolar lavage fluid in patients with idiopathic pulmonary fibrosis
8. Idiopathic diffuse interstitial lung disease
9. Cryptogenic fibrosing alveolitis and lung cancer
10. Skin tests with purified protein derivative, Candida albicans and Trichophyton spp in cryptogenic fibrosing alveolitis and asbestos related lung disease
11. Flowcytometric analysis of bronchoalveolar lavage fluid cells in polymyositis/dermatomyositis with interstitial pneumonia
12. Alveolar macrophage enzymes and C3b receptors in cryptogenic fibrosing alveolitis
13. Circulating immune complexes in idiopathic interstitial pneumonias
14. The role of cytokines in human lung fibrosis
15. Cytokines in human lung fibrosis
16. Overexpression of p53 protein in interstitial lung diseases
17. P21 Waf1/Cip1/Sdi1 and p53 expression in association with DNA strand breaks in idiopathic pulmonary fibrosis
18. Frequent genetic alterations at the microsatellite level in cytologic sputum samples of patients with idiopathic pulmonary fibrosis
19. Clinical characteristics of synchronous multiple lung cancer associated with idiopathic pulmonary fibrosis: A review of Japanese cases
20. Pulmonary fibrosis and lung cancer in the United States: Analysis of multiple cause of death; mortality data, 1979 through 1991
21. Characteristics and management of patients with lung cancer and idiopathic interstitial pneumonia
22. Multiple primary bronchogenic carcinoma with a review of the literature
23. Pulmonary fibrosis and lung carcinoma: A comparative study of metaplastic epithelia in honeycombed areas of usual interstitial pneumonia with and without lung carcinoma
24. The incidence of malignant tumours in patients with respiratory sarcoidosis
25. Risks of malignant neoplasms in patients with pulmonary sarcoidosis
26. Sarcoidosis and malignancy
27. Sarcoidosis and cancer revisited: A long-term follow-up study of 555 Danish sarcoidosis patients
28. Linkage analysis of malignancy-associated sarcoidosis
29. Sarcoid reactions in primary carcinoma: Report of seven cases
30. Sarcoid-like reaction in patients with malignancy
31. Excess death of lung cancer among sarcoidosis patients
32. Increased risk for cancer following sarcoidosis
33. Sarcoidosis and malignant neoplasm: The Mayo Clinic experience
34. Immunosurveillance and cancer
35. Incidence of lung cancer in systemic sclerosis
36. Incidence of cancer among patients with systemic sclerosis
37. Lung cancer and scleroderma
38. Cancer in systemic sclerosis
39. Cancer and systemic sclerosis: An epidemiologic study
40. Immunologic aspects of scleroderma
41. Scleroderma-like lesions and the carcinoid syndrome
42. Polymyositis
43. The overall and temporal association of cancer with polymyositis and dermatomyositis
44. Cancer risk following polymyositis and dermatomyositis: A nationwide cohort study in Denmark
45. Risk of cancer in patients with polymyositis or dermatomyositis: A population-based study
46. Dermatomyositis and malignancy: A review of the literature
47. Polymyositis-dermatomyositis and malignant lesions: Does an association exist?
48. Dermatomyositis and malignancy
49. Elevation of cytokeratin 19 fragment in patients with interstitial pneumonia associated with polymyositis/dermatomyositis
50. Primary Sjögren syndrome (SS) and malignant lymphoma: A retrospective cohort study of 55 patients with SS
51. Long-term follow up of patients with Sjögren's syndrome
52. Increased risk of lymphoma in sicca syndrome
53. Pulmonary lymphoma in Sjögren's syndrome
54. Non-Hodgkin's lymphoma and Sjögren's syndrome: An immunopathological study of 113 patients
55. Early detection of lymphomas in Sjögren syndrome by in situ hybridization for κ and λ light chain mRNA in labial salivary glands
56. High prevalence of B-cell monoclonality in labial gland biopsies of Japanese Sjögren syndrome patients
57. Mixed cryoglobulinemia and monoclonal rheumatoid factor cross-reactive idiotypes as predictive factors for the development of lymphoma in primary Sjögren syndrome
58. Risk of malignancy among patients with rheumatic conditions
59. Rheumatoid arthritis and cancer risk
60. Rheumatoid arthritis and the risk of malignancy
61. Paraproteins in rheumatoid arthritis and related disorders
62. Immunosuppression-associated lymphoproliferative disorders in rheumatic patients
63. Effects of cyclophosphamide on the development of malignancy and on long-term survival of patients with rheumatoid arthritis: A 20-year follow-up study
64. Lymphoma in patients with rheumatoid arthritis: Association with the disease state or methotrexate treatment
65. Incidence of neoplasms in patients with rheumatoid arthritis exposed to different treatment regimens
66. Non-Hodgkin's lymphoma and other cancers among a cohort of patients with systemic lupus erythematosus
67. Increased risk of malignancy in patients with systemic lupus erythematosus
68. Systemic lupus erythematosus: Predisposition for uterine cervical dysplasia
69. Is there an association of malignancy with systemic lupus erythematosus? An analysis of 276 patients under long-term review
70. Malignancy in systemic lupus erythematosus
71. Malignancy in systemic lupus erythematosus: A report of five cases in a series of 96 patients
72. Neoplasms associated with pulmonary eosinophilic granuloma
73. Bronchogenic carcinoma in patients with pulmonary histiocytosis X
74. Langerhans cell and serum precipitating antibodies against fungal antigens in bronchoalveolar cell carcinoma: Possible association with pulmonary eosinophilic granuloma
75. Langerhans cells in Langerhans cell histiocytosis and peripheral adenocarcinomas of the lung
76. Mineral fibers and cancer
77. The relationship between fibrosis and cancer in experimental animals exposed to asbestos and other fibers
78. Asbestos, asbestosis, pleural plaques and lung cancer
79. Asbestos burden and the pathology of lung cancer
80. The relationship between lung cancer and asbestos exposure
81. Association of cigarette smoking and asbestos exposure with location and histology of lung cancer
82. Asbestos and lung cancer: An analysis of the epidemiological evidence on the asbestos-smoking interaction
83. Short-term asbestos work exposure and long term observation
84. Latent periods in lung cancer mortality in relation to asbestos dose and smoking
85. Asbestos-related malignancy
86. Is lung cancer associated with asbestos exposure when there are no small opacities on the chest radiograph?
87. K-ras mutation and occupational asbestos exposure in lung adenocarcinoma: Asbestos-related cancer without asbestosis
88. Possible cellular and molecular mechanisms for asbestos carcinogenicity
89. Mechanisms of asbestos carcinogenesis and toxicity: The amphibole hypothesis revisited
90. Human alveolar macrophage cytokine release in response to in vitro and in vivo asbestos exposure
91. Asbestos and cancer: Human natural killer cell activity is supported by asbestos fibers but can be restored by recombinant interleukins
92. Neoplastic lung lesions in rat after chronic exposure to crystalline silica
93. Silica and lung cancer: A continuing controversy
94. Meta-analysis of studies of lung cancer among silicotics
95. Cancer incidence among Danish stone workers
96. Mortality of a cohort of US workers employed in the crushed stone industry, 1940-1980
97. Vermont granite workers' mortality study
98. Initial findings from a cohort mortality study of British pottery workers
99. Mortality among dust-exposed Chinese mine and pottery workers
100. Lung cancer among workers exposed to silica dust in Chinese refractory plants
101. Silicosis and lung cancer among workers in North Carolina dusty trades
102. A case-referent study on lung cancer mortality among ceramic workers
103. Exposure to crystalline silica and risk of lung cancer: The epidemiological evidence
104. Pneumoconiosis-related lung cancers: Preferential occurrence from diffuse interstitial fibrosis-type pneumoconiosis
105. Animal models of beryllium-induced lung disease
106. Meeting of the IARC Working Group on beryllium, cadmium, mercury, and exposures in the Glass Manufacturing Industry
107. Monographs on the evaluation of the carcinogenic risk of chemicals to humans
108. Mortality patterns from lung cancer and non-neoplastic respiratory disease among white males in the Beryllium Case Registry
109. Beryllium: An etiologic agent in the induction of lung cancer, non-neoplastic respiratory disease, and heart disease among industrially exposed workers
110. Lung cancer incidence among patients with beryllium disease: A cohort mortality study
111. A mortality study of workers at seven beryllium processing plants
112. Risk of gastric cancer in pneumoconiotic coal miners and the effect of respiratory impairment
113. Lung carcinoma by histologic type in coal miners
114. A pathological study of carcinoma of the lung and pneumoconiosis
115. Pneumoconiosis related lung cancers
116. A study of the origin and development of lung cancer
117. Lung scar cancer: A reappraisal
118. Scar cancers of the lung: Observations on their origin and significance
119. The influence of lung scars on primary lung cancer
120. Carcinogenic activity of lipoid substances
121. Peripheral lung cancers arising in scars
122. Adenocarcinoma of the lung in men
123. Scar cancer of the lung: Increase over a 21-year period
124. Prognosis of pulmonary scar carcinoma
125. The association of terminal bronchiolar carcinoma with chronic interstitial inflammation and fibrosis of the lungs
126. Relationship of interstitial pneumonia honeycombing and atypical epithelial proliferation to cancer of the lung
127. Microsatellite DNA instability and loss of heterozygosity in pulmonary sarcoidosis